https://mugglehead.com/auriginal-mining-roger-gold-drilling-resource-update/ Mugglehead Media en 2026-10-15T12:07:09.466Z Auriginal Mining reports 45.5m gold intercept ahead of Roger resource update CVE: AUME, Auriginal Mining Corp, Gold, Copper, Drill results, Quebec https://mugglehead.com/medaro-mining-bastnas-copper-gold-targets/ Mugglehead Media en 2026-10-15T11:37:07.581Z Medaro Mining prioritizes two copper-gold targets at Bastnäs CNSX: MEDA, OTCMKTS: MEDAF, FRA: 1ZY, Medaro Mining Corp, Copper, Gold, Surface sampling, Exploration, Sweden https://mugglehead.com/predator-oil-gas-holdings-placing-trinidad-morocco/ Mugglehead Media en 2026-10-15T11:07:21.112Z Predator Oil & Gas Holdings Plc arranges £2.5M conditional placing LON: PRD, TSE: TXP, LON: TXP, Predator Oil & Gas Holdings Plc, Touchstone Exploration, Oil and gas, Equity financing, Trinidad, Morocco https://mugglehead.com/organigram-global-sanity-integration-operating-model-savings/ Mugglehead Media en 2026-10-15T10:36:13.322Z Organigram Global targets C$8M to C$10M savings after Sanity integration TSE: OGI, NASDAQ: OGI, NASDAQ: TLRY, TSE: TLRY, TSE: WEED, NASDAQ: CGC, Organigram Global, Tilray Brands, Canopy Growth, Cannabis https://mugglehead.com/allied-critical-metals-borralha-eu-strategic-status/ Mugglehead Media en 2026-10-15T10:07:09.488Z Allied Critical Metals gains EU strategic status for Borralha tungsten CNSX: ACM, OTCMKTS: ACMIF, FRA: 0VJ0, Allied Critical Metals, Tungsten, Critical minerals, European Union, Portugal, Permitting https://mugglehead.com/vir-biotechnology-gilead-cancer-collaboration-upfront/ Mugglehead Media en 2026-10-15T09:22:08.745Z Vir Biotechnology signs Gilead cancer deal with US$90M upfront NASDAQ: VIR, NASDAQ: GILD, NASDAQ: IBRX, Vir Biotechnology, Gilead Sciences, ImmunityBio, Cancer, T-cell engagers, Licensing, Biotechnology https://mugglehead.com/digico-infrastructure-reit-sydney-syd1-71mw-tenant-contract/ Mugglehead Media en 2026-10-15T08:37:07.642Z DigiCo Infrastructure REIT signs 15-year contract for 71 MW in Sydney ASX: DGT, ASX: SHA, NASDAQ: BTDR, DigiCo Infrastructure REIT, SHAPE Australia Corporation Limited, Bitdeer Technologies Group, Data centres, Digital infrastructure, Sydney, Leasing https://mugglehead.com/antofagasta-cost-guidance-2027-copper-output/ Mugglehead Media en 2026-10-15T07:41:03.690Z Antofagasta raises cost guidance and sets 2027 copper output range LON: ANTO, LON: RIO, NYSE: RIO, Antofagasta plc, Rio Tinto plc, Copper, Production guidance, Cash costs, Chile https://mugglehead.com/gogold-resources-annual-production-los-ricos-south-construction/ Mugglehead Media en 2026-10-15T05:22:06.459Z GoGold Resources reports 1.86Moz silver-equivalent output and US$288M cash TSE: GGD, OTCMKTS: GLGDF, GoGold Resources, Silver, Production, Mine construction, Mexico https://mugglehead.com/antimony-resources-bald-hill-antimony-drill-results/ Mugglehead Media en 2026-10-15T04:37:08.083Z Antimony Resources reports 21.45% antimony over 1.10m at Bald Hill CNSX: ATMY, OTCMKTS: ATMYF, FRA: K8J0, Antimony Resources Corp, Antimony, Drill results, New Brunswick, Metallurgical testing https://mugglehead.com/wisetech-global-asic-no-action-letters-richard-white/ Mugglehead Media en 2026-10-15T03:52:06.428Z WiseTech Global reports ASIC no-action letters for White and two employees ASX: WTC, WiseTech Global, Logistics software, Regulation, Corporate governance https://mugglehead.com/alkane-resources-peak-hill-deep-drilling/ Mugglehead Media en 2026-10-15T03:07:07.541Z Alkane Resources reports gold 1 km below Peak Hill pit in deep drilling ASX: ALK, TSE: ALK, OTCMKTS: ALKRY, Alkane Resources, Gold, Copper, Drill results, New South Wales https://mugglehead.com/axe-compute-penguin-solutions-ai-deployment-partnership/ Mugglehead Media en 2026-10-15T02:22:06.556Z Axe Compute signs Penguin Solutions to deliver contracted AI projects NASDAQ: AGPU, NASDAQ: PENG, NASDAQ: BTDR, Axe Compute Inc, Penguin Solutions, Bitdeer Technologies Group, AI infrastructure, Data centres, Customer prepayments, Revenue recognition https://mugglehead.com/takeda-orzeyful-japan-china-launch/ Mugglehead Media en 2026-10-15T01:28:41.718Z Takeda launches Orzeyful in Japan and China for narcolepsy type 1 TYO: 4502, NYSE: TAK, NASDAQ: JAZZ, Takeda Pharmaceutical Company Limited, Jazz Pharmaceuticals, Narcolepsy, Drug launch, Orexin, Japan, China https://mugglehead.com/canuc-resources-corporation-east-sudbury-placement/ Mugglehead Media en 2026-10-15T00:25:12.438Z Canuc Resources Corporation raises C$5.99M to fund engineering and drilling CVE: CDA, OTCMKTS: CNUCF, Canuc Resources Corporation, Private placement, Gold, Copper, Ontario https://mugglehead.com/fda-immunitybio-anktiva-papillary-only-bladder-cancer/ Mugglehead Media en 2026-10-14T20:07:08.552Z FDA expands ImmunityBio's Anktiva label to papillary-only bladder cancer NASDAQ: IBRX, NYSE: JNJ, ImmunityBio, Johnson & Johnson, Bladder cancer, FDA approval, Immunotherapy https://mugglehead.com/ultragenyx-pharmaceutical-us203m-priority-review-voucher-sale/ Mugglehead Media en 2026-10-14T19:13:59.405Z Ultragenyx Pharmaceutical agrees to US$203M priority review voucher sale NASDAQ: RARE, Ultragenyx Pharmaceutical, Priority review vouchers, Rare diseases, Cash runway, FDA https://mugglehead.com/p2-gold-sullivan-gabbs-drilling-pit-shell/ Mugglehead Media en 2026-10-14T10:52:07.833Z P2 Gold identifies new gold-copper unit within Sullivan PEA pit shell CVE: PGLD, OTCMKTS: PGLDF, TSE: SSRM, NASDAQ: SSRM, P2 Gold, SSR Mining, Gold, Copper, Drill results, Nevada https://mugglehead.com/rio-tinto-oyu-tolgoi-third-quarter-copper-guidance/ Mugglehead Media en 2026-10-14T09:52:06.549Z Rio Tinto keeps 2026 guidance as Oyu Tolgoi copper output rises 27% LON: RIO, ASX: RIO, NYSE: RIO, TSE: IVN, OTCMKTS: IVPAF, Rio Tinto, Ivanhoe Mines, Copper, Production guidance, Oyu Tolgoi https://mugglehead.com/pharming-group-leniolisib-phase-2-genetic-immune-disorders/ Mugglehead Media en 2026-10-14T09:07:06.444Z Pharming Group reports 26.4% spleen reduction in Phase 2 leniolisib trial AMS: PHARM, NASDAQ: PHAR, NASDAQ: MIRM, Pharming Group, Mirum Pharmaceuticals, Leniolisib, Phase 2, Primary immunodeficiencies, Rare diseases https://mugglehead.com/thor-explorations-q3-gold-output-guidance-cut/ Mugglehead Media en 2026-10-14T08:07:07.222Z Thor Explorations cuts annual gold guidance to 70K to 72K oz CVE: THX, LON: THX, TSE: AG, NYSE: AG, FRA: FMV, Thor Explorations Ltd, First Majestic Silver Corp, Gold, Quarterly production, Production guidance https://mugglehead.com/mayne-pharma-cosette-takeover-appeal-dismissal/ Mugglehead Media en 2026-10-14T07:22:06.690Z Mayne Pharma wins dismissal of Cosette appeal over abandoned takeover ASX: MYX, NASDAQ: LQDA, NASDAQ: ANIP, NYSEARCA: XBI, Mayne Pharma Group, Liquidia Corporation, ANI Pharmaceuticals, State Street SPDR S&P Biotech ETF, Takeovers, Appeals https://mugglehead.com/grange-resources-savage-river-underground-development/ Mugglehead Media en 2026-10-14T06:37:06.494Z Grange Resources approves A$287M Savage River underground development ASX: GRR, Grange Resources, Iron ore, Mine development, Tasmania https://mugglehead.com/regis-resources-mcphillamys-heritage-declaration-court-ruling/ Mugglehead Media en 2026-10-14T05:37:08.121Z Regis Resources wins ruling against McPhillamys heritage declaration ASX: RRL, Regis Resources, Gold, McPhillamys, Cultural heritage, Court ruling https://mugglehead.com/olympus-corporation-fda-warning-six-facilities/ Mugglehead Media en 2026-10-14T04:52:07.044Z Olympus Corporation receives FDA warning over six facilities TYO: 7733, NYSE: BSX, NYSE: JNJ, Olympus Corporation, Boston Scientific Corporation, Johnson & Johnson, FDA, Medical devices, Quality systems, Endoscopy https://mugglehead.com/xtra-gold-resources-kibi-indicated-gold-resource/ Mugglehead Media en 2026-10-14T03:52:06.621Z Xtra-Gold Resources lifts Kibi indicated gold resource 33% to 1.4Moz TSE: XTG, OTCMKTS: XTGRF, Xtra-Gold Resources, Gold, Mineral resources, Ghana, Kibi https://mugglehead.com/liquidia-corporation-yutrepia-litigation-settlement/ Mugglehead Media en 2026-10-14T02:52:06.549Z Liquidia Corporation agrees to US$380.7M litigation settlement NASDAQ: LQDA, NASDAQ: UTHR, NYSE: BMY, Liquidia Corporation, United Therapeutics Corporation, Bristol Myers Squibb, YUTREPIA, Patent litigation, Pulmonary hypertension, Settlement https://mugglehead.com/paladin-energy-september-quarter-uranium-production-guidance/ Mugglehead Media en 2026-10-14T01:52:07.148Z Paladin Energy reports lower uranium output and keeps annual guidance ASX: PDN, TSE: PDN, OTCMKTS: PALAF, TSE: NXE, NYSE: NXE, ASX: NXG, Paladin Energy Ltd, NexGen Energy Ltd, Uranium, Quarterly results https://mugglehead.com/strive-sats-preferred-offering-dividend/ Mugglehead Media en 2026-10-14T00:54:41.745Z Strive proposes 15% preferred offering with US$75M annual dividend cost NASDAQ: ASST, NASDAQ: SATA, NASDAQ: MSTR, Strive Inc, Strategy Inc, Bitcoin, Preferred stock, Financing, Dividends https://mugglehead.com/canopy-growth-smiths-falls-eu-gmp-softgels-packaging/ Mugglehead Media en 2026-10-13T15:22:06.503Z Canopy Growth gains EU GMP certification for Smiths Falls softgels TSE: WEED, NASDAQ: CGC, TSE: TLRY, NASDAQ: TLRY, Canopy Growth, Tilray Brands, Medical cannabis, EU-GMP, Germany, Softgels https://mugglehead.com/digi-power-x-alabama-us200m-debt-commitment/ Mugglehead Media en 2026-10-13T14:22:06.670Z Digi Power X receives US$200M debt commitment for Alabama AI campus NASDAQ: DGXX, NASDAQ: BTDR, Digi Power X Inc, Bitdeer Technologies Group, Data centres, Project financing, AI infrastructure, Alabama https://mugglehead.com/tilray-brands-portugal-in-house-cannabis-testing-approval/ Mugglehead Media en 2026-10-13T13:37:06.476Z Tilray Brands gains approval for in-house cannabis testing in Portugal NASDAQ: TLRY, TSE: TLRY, TSE: ACB, NASDAQ: ACB, Tilray Brands, Aurora Cannabis, Medical cannabis, Portugal, EU-GMP, Quality testing https://mugglehead.com/johnson-johnson-q3-2026-results-guidance/ Mugglehead Media en 2026-10-13T12:37:07.413Z Johnson & Johnson raises 2026 outlook after US$25.4B quarterly sales NYSE: JNJ, NYSE: ABBV, NYSE: BMY, Johnson & Johnson, AbbVie, Bristol Myers Squibb, Earnings, Guidance, Immunology, Medical technology